This federal Project Grant award, funded under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program by the Agency for Healthcare Research and Quality (AHRQ), aims to reduce variation and disparities in radiologist recommendations for additional imaging (RAI) in head and neck radiology. The $795,826 award to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, will fund a 5-year research project to: 1) Identify sociodemographic...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $691,176 to Brigham & Women's Hospital Inc. to conduct a study comparing two implementation strategies to facilitate decentralized breast ultrasound services at district hospitals in Rwanda. The project aims to 1) assess the impact of teleultrasound supervision versus asynchronous virtual feedback on penetration of guideline-concordant breast ultrasound, 2) compare the...
This Project Grant from the National Science Foundation's Computer and Information Science and Engineering program (CFDA 47.070) provides $800,000 to develop an intelligent radiology platform through human-machine cooperation. The awardee, Georgia Tech Research Corporation, will create an accurate medical image labeling tool using state-of-the-art artificial intelligence algorithms to maximize accuracy and minimize inter- and intra-reader variability among radiologists. The tool will provide...
This $717,712 Project Grant from the National Science Foundation's Division of Information and Intelligent Systems, under the Computer and Information Science and Engineering program (CFDA 47.070), will support the development and evaluation of a knowledge-enhanced and interpretable radiology report generation framework using longitudinal, multimodal electronic health record data and domain knowledge. The awardee, Joan & Sanford I Weill Medical College of Cornell University, will build a...
This $962,560 Project Grant (R01CA285369) awarded by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to modify and clinically validate the IRIS device, a handheld thermal ablation device and digital colposcope designed for cervical cancer screening and treatment in low- and middle-income countries (LMICs). The key products and services to be delivered include: 1) Modifying the existing IRIS prototype to include an endocervical...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) provides $185,625 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a novel magnetic resonance imaging (MRI) technology. The key product is a "multiphoton parallel transmit" approach that uses a conventional...
This $1,063,155 Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to develop and test a novel quality assurance (QA) device for advanced radiation therapy techniques. The device, named the RetrieveTM, will enable more precise, efficient, and comprehensive QA compared to existing solutions. The project seeks to: 1) refine the hardware to measure machine performance metrics to within 0.5 mm and 1% relative dose,...
The Georgia Association For Primary Health Care, Inc. (GAPHC) was awarded a $1,400,000 five-year Project Grant by the U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) under the Rural Telemedicine Grants program (CFDA 93.211). The grant aims to integrate behavioral health services into primary care through the use of evidence-based telehealth technologies in rural and underserved communities across Georgia. The project will leverage...
This $2,278,167 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of non-invasive transcranial volumetric super-resolution imaging, targeted contrast agents, and image-guided focused ultrasound surgery. The key products and services to be delivered through this 4-year project (Aug 2024 - Apr 2028) include:...
This federal Cooperative Agreement award of $539,352, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), will support a project to incorporate portable, low-field brain magnetic resonance imaging (MRI) into a population-representative study of Alzheimer's disease (AD) and related dementias (ADRD) in rural South Africa. The project will establish the infrastructure and resources to conduct high-fidelity, high-throughput brain imaging studies in a rural setting,...